Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRF1 | P14222 | 8/20 | 0.42 |
| ▸ | PGR | P06401 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | APP | P05067 | 1/20 | 0.35 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20043836 | 0.93 | PGR (0.43) | PRF1PGRMAPTAPPCYP2E1 | |
| SCHEMBL23278536 | 0.89 | PRF1 (0.43) | PRF1PGRMAPTAPPCYP2E1 | |
| SCHEMBL20365628 | 0.85 | PGR (0.42) | PRF1PGRMAPTAPPCYP2E1 | |
| SCHEMBL20044280 | 0.82 | PGR (0.35) | PRF1PGRMAPTAPPCYP2C9 | |
| SCHEMBL20247154 | 0.81 | PGR (0.32) | PRF1PGR | |
| SCHEMBL23082566 | 0.80 | CYP2A6 (0.39) | MAPTCYP2A6 | |
| SCHEMBL20043746 | 0.79 | PRF1 (0.36) | PRF1PGRMAPTAPP | |
| SCHEMBL20042465 | 0.78 | PRF1 (0.35) | PRF1PGRAPP | |
| SCHEMBL20044395 | 0.78 | PRF1 (0.35) | PRF1PGRAPP | |
| SCHEMBL20044318 | 0.78 | PRF1 (0.37) | PRF1PGRMAPTAPP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11183637-B2 | Organic photodetector | Raynergy Tek Incorporation (TW) | 2021-11-23 | — | — | US | disclosed |
| US-10991893-B2 | Organic semiconducting compounds | Raynergy Tek Incorporation (TW) | 2021-04-27 | — | — | US | disclosed |
| US-20200052227-A1 | ORGANIC SEMICONDUCTING COMPOUNDS | MERCK PATENT GMBH (DE) | 2020-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200052227-A1 | ORGANIC SEMICONDUCTING COMPOUNDS | OCIAD2, OCIAD1, OSTC | PRF1 3167/4885PGR 1755/4885MAPT 32/4885 |
| US-10991893-B2 | Organic semiconducting compounds | OCIAD2, OCIAD1, OSTC | PRF1 3167/4885PGR 1755/4885MAPT 32/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.